Modulation of hepatic stellate cells by Mutaflor ® probiotic in non-alcoholic fatty liver disease management.
Noha M HanySanaa EissaManal BasyouniAmany Helmy HasaninYasmin M Aboul-ElaNagwa M Abo ElmagdIman Fawzy MontasserMahmoud A AliPaul J SkippMarwa MatboliPublished in: Journal of translational medicine (2022)
may slow the progression of NAFLD/NASH by modulating a genetic-epigenetic network linked to HSC signaling. The probiotic may be a useful modality for the prevention and treatment of NAFLD/NASH.